Skip to main content Accessibility help
×
Home

Antimicrobial resistance patterns in urinary E. coli isolates after a change in a single center’s guidelines for uncomplicated cystitis in ambulatory settings

  • Patrick P. Ryan (a1) (a2) (a3), Bryan C. Knepper (a4), Rachel M. Everhart (a2) and Connie S. Price (a3) (a5)

Abstract

Recommending nitrofurantoin to treat uncomplicated cystitis was associated with increased nitrofurantoin use from 3.53 to 4.01 prescriptions per 1,000 outpatient visits, but nitrofurantoin resistance in E. coli isolates remained stable at 2%. Concomitant levofloxacin resistance was a significant risk for nitrofurantoin resistance in E. coli isolates (odds ratio [OR], 2.72; 95% confidence interval [CI], 1.04–7.17).

Copyright

Corresponding author

Author for correspondence: Patrick Ryan, Email: patrick.ryan@dhha.org

Footnotes

Hide All

Previous Presentation: This work was previously presented in a poster at IDWeek 2016 on October 28, 2016, in New Orleans, Louisiana.

Footnotes

References

Hide All
1.Schappert, SR, Rechtsteiner, EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 2011;169:138.
2.Etienne, M, Lefebvre, E, Frebourg, N, Hamel, H, Pestel-Caron, M, Caron, F. Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series. BMC Infect Dis 2014;14:137.
3.Davey, P, Marwick, CA, Scott, CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017;2:CD003543.
4.Zhanel, GG, Hisanaga, TL, Laing, NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agent 2006;27:468475.
5.Burman, WJ, Breese, PE, Murray, BE, et al. Conventional and molecular epidemiology of trimethoprimsulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 2003;115:358364.
6.Johnson, L, Sabel, A, Burman, WJ, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008;121:876884.
7.Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103e120.
8.Webber, MA,Piddock, LJV. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003;51:911.
9.Sulavik, MC, Houseweart, C, Cramer, C, et al. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother 2001;45:11261136.
10.Paterson, DL. “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38 Suppl 4:S341S345.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed